Restriction endonucleases are key bioreagents for genetic engineering. Although over 200 specificities exist currently, there is a need for additional enzymes that recognize novel sequences for mapping and other applications in molecular biology. The investigators propose to develop new, computationally-based approaches to screening public sequence databases to identify candidates for new restriction enzymes. The candidate genes identified by the computational methods will be screened biochemically to test predictions. New specificities will be fully characterized and offered for sale.

Proposed Commercial Applications

From this project we will discover new restriction enzymes that we will sale to the research community. If we are lucky, some of them may also be used in diagnostic application.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44GM056535-03
Application #
6180912
Study Section
Special Emphasis Panel (ZRG1-SSS-Y (01))
Program Officer
Wolfe, Paul B
Project Start
1997-09-01
Project End
2001-07-31
Budget Start
2000-08-01
Budget End
2001-07-31
Support Year
3
Fiscal Year
2000
Total Cost
$355,403
Indirect Cost
Name
New England Biolabs, Inc.
Department
Type
DUNS #
066605403
City
Ipswich
State
MA
Country
United States
Zip Code
01938